Artículos por temáticas

Recent Insights on the Role of Nuclear Receptors in Alzheimer's Disease: Mechanisms and Therapeutic Application

Shan X, Li D, Yin H, Tao W, Zhou L, Gao Y, Xing C, Zhang C.

Int J Mol Sci. 2025 Jan 30;26(3):1207. doi: 10.3390/ijms26031207.

Roles of the Receptor for Advanced Glycation End Products and Its Ligands in the Pathogenesis of Alzheimer's Disease

Li W, Chen Q, Peng C, Yang D, Liu S, Lv Y, Jiang L, Xu S, Huang L.

Int J Mol Sci. 2025 Jan 5;26(1):403. doi: 10.3390/ijms26010403.

Unveiling the hippocampal subfield changes across the Alzheimer's disease continuum: a systematic review of neuroimaging studies

Zilioli A, Pancaldi B, Baumeister H, Busi G, Misirocchi F, Mutti C, Florindo I, Morelli N, Mohanty R, Berron D, Westman E, Spallazzi M.

Brain Imaging Behav. 2025 Feb;19(1):253-267. doi: 10.1007/s11682-024-00952-0. Epub 2024 Oct 23.

Recent advancements in the understanding of the alterations in mitochondrial biogenesis in Alzheimer's disease

Singh S, Singh RK.

Mol Biol Rep. 2025 Jan 29;52(1):173. doi: 10.1007/s11033-025-10297-6.

Association between apolipoprotein E ε4 status and the risk of Alzheimer's disease: a meta-analysis

Ren Z, Guan Z, Guan Q, Guan H, Guan H.

BMC Neurosci. 2025 Jan 24;26(1):5. doi: 10.1186/s12868-024-00914-8.

C/EBPβ in Alzheimer's disease: An integrative regulator of pathological mechanisms

Luo X, Liang J, Lei X, Sun F, Gong M, Liu B, Zhou Z.

Brain Res Bull. 2025 Feb;221:111198. doi: 10.1016/j.brainresbull.2025.111198. Epub 2025 Jan 7.

Modulating Neuroinflammation as a Prospective Therapeutic Target in Alzheimer's Disease

Lee E, Chang Y.

Cells. 2025 Jan 22;14(3):168. doi: 10.3390/cells14030168.

Reinforcing Nrf2 Signaling: Help in the Alzheimer's Disease Context

la Torre A, Lo Vecchio F, Angelillis VS, Gravina C, D'Onofrio G, Greco A.

Int J Mol Sci. 2025 Jan 28;26(3):1130. doi: 10.3390/ijms26031130.

Evidence Suggesting That Alzheimer's Disease May Be a Transmissible Disorder

Saw G, Yi LX, Tan EK, Zhou ZD.

Int J Mol Sci. 2025 Jan 9;26(2):508. doi: 10.3390/ijms26020508.

The role of lipid metabolism in cognitive impairment

Xu M, Wang L, Meng Y, Kang G, Jiang Q, Yan T, Che F.

Arq Neuropsiquiatr. 2025 Jan;83(1):1-13. doi: 10.1055/s-0044-1792097. Epub 2025 Jan 15.

Multifunctional Tasks and an Energy Crisis are Crucial Players in Determining the Vulnerability of the Entorhinal Cortex to Early Damage in Alzheimer's Disease

Sivanesan S, Howell MD, Kaushik V, Jayakumar R, Pari SM, Goyal P.

Curr Alzheimer Res. 2025;21(5):295-311. doi: 10.2174/0115672050324909240823104209.

From Genetics to Neuroinflammation: The Impact of ApoE4 on Microglial Function in Alzheimer's Disease

Dias D, Portugal CC, Relvas J, Socodato R.

Cells. 2025 Feb 7;14(4):243. doi: 10.3390/cells14040243.

Motor abilities and cognitive performance in Latinos with autosomal dominant Alzheimer's disease

Petkus AJ, Sonti AN, Montoya L, Sagare A, Ringman JM.

J Prev Alzheimers Dis. 2025 Jan;12(1):100010. doi: 10.1016/j.tjpad.2024.100010. Epub 2025 Jan 1.

Comparison of the amyloid plaque proteome in Down syndrome, early-onset Alzheimer's disease, and late-onset Alzheimer's disease

Martá-Ariza M, Leitner DF, Kanshin E, Suazo J, Giusti Pedrosa A, Thierry M, Lee EB, Devinsky O, Drummond E, Fortea J, Lleó A, Ueberheide B, Wisniewski T.

Acta Neuropathol. 2025 Jan 18;149(1):9. doi: 10.1007/s00401-025-02844-z.

Investigation of patterns and associations of neuroinflammation in cognitive impairment

Gan R, Xie H, Zhao Z, Wu X, Wang R, Wu B, Chen Q, Jia Z.

Cereb Cortex. 2025 Feb 5;35(2):bhaf013. doi: 10.1093/cercor/bhaf013.